Related Experiment Video

Updated: Dec 18, 2025

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment
11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

11.3K

Cytokines that target immune killer cells against tumors

Jian Qiao1, Yang-Xin Fu2

  • 1The Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, 75235, USA. Jian.Qiao@UTSouthwestern.edu.

Cellular & Molecular Immunology
|June 12, 2020
PubMed

Insights

Cytokines like IL-2, IL-15, and IL-10 show promise for cancer immunotherapy but face challenges. New strategies aim to improve their effectiveness and reduce toxicity for better cancer treatment.

Area of Science:

  • Immunology
  • Oncology
  • Pharmacology

Background:

  • T-cell-stimulating cytokines are vital for cancer immunotherapy.
  • Current cytokine therapies face limitations including short half-life, toxicity, and broad activity.
  • Improving the therapeutic index of cytokines is crucial for enhancing efficacy.

Purpose of the Study:

  • To review the progress of IL-2, IL-15, and IL-10 in preclinical and clinical cancer immunotherapy.
  • To discuss strategies for overcoming therapeutic barriers associated with cytokine-based treatments.
  • To provide perspectives on developing novel cytokine-based immunotherapies.

Main Methods:

  • Review of preclinical studies and clinical applications of IL-2, IL-15, and IL-10.
  • Analysis of strategies to enhance cytokine efficacy and reduce toxicity.
  • Discussion of future directions in cytokine-based immunotherapy.

Main Results:

  • Cytokines IL-2, IL-15, and IL-10 demonstrate potent antitumor effects.
  • Various approaches are being developed to improve cytokine delivery and targeting.
  • Modifications aim to enhance binding to effector immune cells and prolong half-life.

Conclusions:

  • Optimized cytokine therapies hold significant potential for cancer treatment.
  • Further research into novel strategies is needed to maximize the benefits of cytokine immunotherapy.
  • Targeted delivery and modified cytokine properties can improve therapeutic outcomes in cancer.
Keywords:
IL-10IL-15IL-2cancercytokine therapy

More Related Videos

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

1.2K
Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.0K